Reply to the letter to the editor: adjuvant nivolumab for the management of the pathological residual disease in esophageal or junctional tumors: a word of caution by P.K. Garg, R. Kumar and P. Dixit [0.03%]
来信答复：P.K. Garg，R. Kumar和P. Dixit关于残余病的信——谨慎使用纳武单抗辅助治疗食管或食管胃交界部肿瘤
E C Smyth,V Gambardella,A Cervantes et al.
E C Smyth et al.
Nutritional support during the hospital stay reduces mortality in patients with different types of cancers: secondary analysis of a prospective randomized trial [0.03%]
住院期间的营养支持可降低不同类型癌症患者的死亡率：前瞻性随机试验的二次分析
L Bargetzi,C Brack,J Herrmann et al.
L Bargetzi et al.
Background: Nutritional support in patients with cancer aims at improving quality of life. Whether use of nutritional support is also effective in improving clinical outcomes requires further study. ...
The positive effect of immune checkpoint inhibitor-induced thyroiditis on overall survival accounting for immortal time bias: a retrospective cohort study of 6596 patients [0.03%]
免疫检查点抑制剂诱导性甲状腺炎对总生存期的正向影响——一项纳入6596例患者的回顾性队列研究（兼论不朽时间偏倚）
S Street,D Chute,I Strohbehn et al.
S Street et al.
R Dienstmann,D Tamborero
R Dienstmann
Corrigendum to 'Role of up-front autologous stem-cell transplantation in peripheral T-cell lymphoma for patients in response after induction: an analysis of patients from LYSA centers': [Annals of Oncology Volume 29, Issue 3, March 2018, Pages 715-723] [0.03%]
前期自体干细胞移植在诱导治疗后获得缓解的外周T细胞淋巴瘤患者中的作用：来自LYSA中心患者的分析(Annals of Oncology Volume 29, Issue 3, March 2018, Pages 715-723)的勘误表
G Fossard,F Broussais,I Coelho et al.
G Fossard et al.
Bringing safe and effective therapies to premenopausal women with breast cancer: efforts to broaden eligibility criteria [0.03%]
扩大乳腺癌治疗纳入范围，让更多绝经前女性获益
J J Gao,D Krol,P Narayan et al.
J J Gao et al.
Adjuvant nivolumab for the management of pathological residual disease in esophageal or junctional tumors: a word of caution [0.03%]
病理残留病灶的辅助纳武单抗治疗：慎重其事
P K Garg,R Kumar,P Dixit
P K Garg
F H Blackhall
F H Blackhall